# VaxSyna Inc: Form D filing

VaxSyna Inc, a biotechnology company in Franklin, NH, filed a Form D with the SEC in 2022. The latest, on September 23, 2022, reports an offering of no set size with nothing sold yet to 12 investors.

Find out what VaxSyna Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20VaxSyna%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=VaxSyna%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fvaxsyna-inc-1947994)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20VaxSyna%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=VaxSyna%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fvaxsyna-inc-1947994)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Hampshire](https://specstream.ai/data/form-d/state/new-hampshire): 127 rows, by operating companies, filed since November 1, 2024, $6.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-hampshire
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 45 CIRCLE, Franklin, NH, 03235
- Phone: 19285838404
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2021
- Revenue range: Not Applicable
- Exemptions claimed: Rule 504
- SEC identifier (CIK): 1947994

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 23, 2022 | New notice | Indefinite | $0 | Indefinite | 12 | Jul 11, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1947994/000194799422000001/0001947994-22-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Mary Pardhe | Executive Officer |  |
| Joseph Hunter | Executive Officer |  |
| Kaitlyn Morse | Executive Officer |  |

[Every Form D from the week of Sep 19, 2022](https://specstream.ai/data/form-d/week/2022-09-19) · [All recent filings in New Hampshire](https://specstream.ai/data/form-d/state/new-hampshire) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what VaxSyna Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).